TRIFLURIDINE Drug Patent Profile
✉ Email this page to a colleague
When do Trifluridine patents expire, and what generic alternatives are available?
Trifluridine is a drug marketed by Hikma and Sandoz and is included in two NDAs.
The generic ingredient in TRIFLURIDINE is trifluridine. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trifluridine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trifluridine
A generic version of TRIFLURIDINE was approved as trifluridine by SANDOZ on October 6th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIFLURIDINE?
- What are the global sales for TRIFLURIDINE?
- What is Average Wholesale Price for TRIFLURIDINE?
Summary for TRIFLURIDINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 91 |
| Clinical Trials: | 65 |
| Patent Applications: | 4,140 |
| Drug Prices: | Drug price information for TRIFLURIDINE |
| DailyMed Link: | TRIFLURIDINE at DailyMed |
Recent Clinical Trials for TRIFLURIDINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The First Affiliated Hospital with Nanjing Medical University | Phase 2 |
| Sun Yat-sen University | Phase 2 |
| Yonsei University | Phase 1/Phase 2 |
Pharmacology for TRIFLURIDINE
| Drug Class | Nucleoside Analog Antiviral Nucleoside Metabolic Inhibitor |
| Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for TRIFLURIDINE
Anatomical Therapeutic Chemical (ATC) Classes for TRIFLURIDINE
US Patents and Regulatory Information for TRIFLURIDINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | TRIFLURIDINE | trifluridine | SOLUTION/DROPS;OPHTHALMIC | 205438-001 | Jul 28, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | TRIFLURIDINE | trifluridine | SOLUTION/DROPS;OPHTHALMIC | 074311-001 | Oct 6, 1995 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
